Crackdown on sale of banned painkiller drug

PUNE, 10 Aug 2013: There is rampant sale of the banned painkiller dextropropoxyphehne (DXP) in Pune and elsewhere in the state. The Food and Drugs Administration (FDA) officials, in a two-week operation, have nabbed a drug consignee agent and a pharma company's depot manager in Pune. Together, they had sold capsules containing the drug worth over Rs 60 lakh in Pune, the rest of Maharashtra and Goa, officials said. The agent was nabbed on Thursday night in Uruli Devachi. He was attached to a Hyderabad-based pharma company and distributed the drug through a network spread in Maharashtra and Goa. FDA officials have filed an FIR against the agent with Loni Kalbhor police station under section 26 (A) of Drugs and Cosmetics Act 1940 and section 328 of Indian Penal Code (causing hurt by means of poison, with intent to commit an offence).

FLAG HOSTING AT....................

Belgaum:-(15/8/2013) Flag hosting ceremony at Assistant Drugs Control Department Belgaum(Karnataka)
                Shri K.S.Mallikarjun (Assist.Drugs Controller),Shri Sharanbasappa Hanmanal(D.I.),Shri Gururaj
                (D.I.)& Office staff with the members of The Belgaum Chemists & Druggists Association,& The
                Belgaum C&D Welfare Association were present.
                                                                  VANDE MATRAM

HAPPY INDEPENDENCE DAY..............

BGMCHEMIST BLOG WISHES YOU HAPPY INDEPENDENCE DAY.
VANDE MATRAM JAI HIND.

BGMCHEMIST WISHES..................

BELGAUM-(9/8/2013) BGMCHEMIST WISHES HAPPY RAMADAN AND EID MUBARAK

Delhi HC sends notice to Centre on DPCO issue as more companies challenge new drug pricing

New Delhi, 5 Aug 2013: The Delhi High Court has sent notices to the Centre and the National Pharmaceutical Pricing Authority (NPPA) as seven more companies moved the court to question the newly revised prices of formulations as per the Drug Price Control Order (DPCO) 2013. The Court sent notices to the Centre and others including NPPA on a petition filed by the Indian Drug Manufacturers Association (IDMA) on the issue of drug pricing. The case came up before the bench of Acting Chief Justice B D Ahmed and Justice Vibhu Bakhru on Monday.

Over 22 lakh tablets, including banned drug, seized

PATIALA, 6 AUG 2013: In one of the major drug recoveries in the state in recent years, the Patiala police claimed to have seized over 22 lakh tablets of various formulations, including 2.8 lakh tablets of banned drug, near Shambhu barrier on Monday. The drugs were seized from a truck coming from Delhi to Ludhiana by a joint team of drug authorities and the district police. Rajpura superintendent of police Bhupinder Singh Khatra said that around 10 lakh tablets of Mycrolit (Diphenoxilate), over nine lakh tablets of Lomotil and around 2.8 lakh tablets of Pravon Spas (Dextropropoxyphene Hydrochloride) were recovered from the truck.

Pending HC decision new drug price order must be complied with’

New Delhi, 8 Aug 2013: The government on Wednesday told pharmaceutical companies that pending the decision of the Delhi High Court, new drug price control orders (DPCO), as per the National Pharmaceutical Pricing Policy 2012, would have to be complied with.

Drugs seized, one held for illegal collection

IMAPUR, 22 JULY 2013 (MExN): Excise personnel posted at the Chumukedima Check-post on July 21 confiscated 33 thousand capsules of restricted pharmaceutical drug - spasmo proxyvon. The restricted drug was found in the possession of one Md. Ziaour Rahman (22 years), hailing from Lilong Turel Ahanbi, Thoubal, Manipur.

Ban lifted, diabetes drug will now come with warning

Mumbai, 2 Aug 2013: Following a series of protests from doctors across the country, the Ministry of Health and Family Welfare has after several rounds of meetings finally revoked the June 18 ban on the antidiabetic drug pioglitazone. An insulin sensitiser, the drug is considered by experts to be the most effective of its kind, provided it is administered in the correct dosage. The lifting of the ban will bring relief to over 35 lakh diabetes patients across the country who were left to either switch to insulin or opt for costlier (yet less effective) drugs. The ministry's notification issued on July 31 states that while the central government was of the opinion that the use of pioglitazone involved risk to human life, the DTAB examined the issue and suggested that the drug should not be banned. Conditions for sale

No confusion about implementation of new drug prices following HC order: DoP

New Delhi, 1 Aug 2013: The Department of Pharmaceuticals (DoP) has clarified that there was no confusion about the implementation of the new prices as per the Drugs Price Control Order (DPCO) 2013 in the market, in the wake of the orders by the Delhi High Court in two cases on Tuesday. The Court has not allowed the companies to sell the old stocks as per the old prices, but has asked them to instead furnish supplementary price list to the retailers and the drug controllers in respect of formulations covered under various price notifications, DoP joint secretary Shambhu Kallolikar said.

FIR for alleged illegal sale and distribution of Spasmoproxyvon Capsules

Mumbai, 1 Aug 2013: The Maharashtra Foods & Drugs Administration (FDA) has registered a first information report (FIR) in Pune against Wockhardt’s clearing and forwarding outlets (entities responsible for maintaining stocks of the company’s products and forwarding to stockists on request) for the alleged illegal sale and distribution of spasmoproxyvon capsules. The FIR was lodged according to the provisions of the Drugs & Cosmetics Act, 1940, and the Indian Penal Code.

DoP rejects review petition by Lupin against NPPA price fixation order

New Delhi, 30 July 2013: The Department of Pharmaceuticals (DoP) has rejected the two review petitions including the one by Lupin against fixation of price of Levo-salbutamol by the National Pharmaceutical Pricing Authority (NPPA).

NPPA fixes prices of 26 more formulations, withdraws notifications on two formulations announced earlier

New Delhi, 25 July 2013: The National Pharmaceutical Pricing Authority (NPPA) has revised the prices of 26 more formulations as part of the ongoing exercise of refixing the prices of essential medicines covered under the new pharmaceutical policy and the Drug Price Control Order (DPCO) 2013. The pharma pricing regulator has also withdrawn the price fixation in the case of two formulations, announced in its earlier notifications. “In exercise of the powers, conferred by paragraph 4, 11 and 14 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the May 30, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby withdraw the Gazette Notification S.O. No. 1818(E) dated June 21, 2013, relating to Glucose Injection 5% isotonic, with immediate effect,” said the notification dated July 22. In the similar way, the regulator also withdrew the earlier notification with regard to Oral Rehydration Salts Powder for Solution, with immediate effect. Earlier notification was made on June 14. Prices of both these formulations were fixed as per the new DPCO.